Lifecare AS (DE:LFC) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Lifecare ASA, a medical sensor developer, has commenced longevity trials for its next-generation Continuous Glucose Monitor (CGM) system in dogs, in collaboration with the Norwegian University of Life Sciences. The trials follow successful in-vitro testing and are a significant move towards the product’s readiness for the veterinary market. The study’s results will inform the progress towards automated production and eventual market release.
For further insights into DE:LFC stock, check out TipRanks’ Stock Analysis page.
